ArticleTherapeutic advances in drug safety2022
The response to the COVID-19 pandemic trusted in pharmacovigilance to diminish communication risk.
Gustavo A QuinteroPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it